Helixmith Co., Ltd (KOSDAQ:084990)
 5,320.00
 +320.00 (6.40%)
  Oct 31, 2025, 1:40 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 230.23 billion as of October 30, 2025. Its market cap has increased by 43.88% in one year.
Market Cap 
 230.23B
Enterprise Value 
 148.31B
Revenue 
 4.98B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
5,320.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 230.23B, a decrease of -3.52%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 244.05B | 96.30% | 
| Dec 30, 2024 | 124.33B | -51.50% | 
| Dec 28, 2023 | 256.37B | -35.45% | 
| Dec 29, 2022 | 397.14B | -53.54% | 
| Dec 30, 2021 | 854.88B | -3.11% | 
| Dec 30, 2020 | 882.29B | -55.53% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 86.90T | 
| Celltrion | 38.90T | 
| ALTEOGEN | 24.95T | 
| SK Biopharmaceuticals | 8.97T | 
| Yuhan | 8.77T | 
| HLB Co., Ltd. | 6.30T | 
| Peptron | 6.18T | 
| PharmaResearch | 5.36T |